Administration Unveils Proposed Framework for Exercising “March in” Rights on High-Priced Drugs
- December 08, 2023
The Biden administration released December 7 a proposed framework for federal agencies to exercise “march in” rights on pricey drugs that were developed using federal funds.
ARTICLE TAGS
You must be logged in to access this content.